IWC
MEDS

Integrated Wealth Concepts’s DataMeds AI MEDS Stock Holding History

Integrated Wealth Concepts’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78 Buy
+25
New +$123 ﹤0.01% 5827

Other funds holding MEDS

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Integrated Wealth Concepts's MEDS Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in DataMeds AI (MEDS) in Q2 2026: 25 shares worth $78. The stake represents ﹤0.01% of the portfolio and ranks #5827 among its holdings.

10 funds tracked by Wall St. Rank hold MEDS as of Q2 2026.

  • Integrated Wealth Concepts held 25 shares of DataMeds AI worth $78 as of Q2 2026.
  • DataMeds AI was a new Integrated Wealth Concepts position in Q2 2026.
  • DataMeds AI made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5827 holding.
  • 10 funds tracked by Wall St. Rank held DataMeds AI as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.